Answers are grounded in this paper and cite their sources.
// Peng Xu 1, * , Jie Yao 1, * , Jin He 1 , Long Zhao 1 , Xiaodong Wang 1 , Zhennan Li 1 , Jianjun Qian 1 1 Department of Hepatobiliary and Pancreatic Surgery, Northern Jiangsu People’s Hospital, Clinical medical college of Yangzhou University, Yangzhou city, Jiangsu Provence of P. R. China, 225001 * These authors have contributed equally to this work Correspondence to: Jie Yao, e-mail: docyao@126.com Keywords: CIP2A, pancreatic ductal adenocarcinoma, gemcitabine, prognosis, overall survival Received: November 03, 2015 Accepted: January 29, 2016 Published: February 17, 2016 ABSTRACT Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an oncoprotein which participates in inhibiting tumor apoptosis in pancreatic cancer cells. Using immunohistochemical staining, we investigated the expression of CIP2A protein in 72 cases of human pancreatic ductal adenocarcinoma (PDAC) tissue and 27 cases of adjacent normal pancreatic tissue. The positive rate of CIP2A protein expression in pancreatic cancer tissue was70.83 %, which was significantly higher than that in adjacent non- cancerous pancreatic tissue (11.11%). The expression of CIP2A was found to be correlated with TNM stage, but not correlated with age, gender, tumor location, smoking status, alcohol consumption, diabetes, high blood pressure, BMI, tumor size, lymph node metastasis or distant metastases. Kaplan- Meier survival analysis showed that patients with positive CIP2A protein expression had a lower overall survival rate than patients without CIP2A expression. COX regression analysis indicated that expression of CIP2A was an independent prognostic factor for pancreatic ductal adenocarcinoma. In addition, down-regulation of CIP2A inhibited cell proliferation and increased sensitivity to gemcitabine in pancreatic cancer cells by decreasing AKT signaling pathway. Our results indicated that down-regulation of CIP2A could be a novel therapeutic strategy for pancreatic cancer
No takes yet. Share an insight, caveat, or question.
Xu et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: